We are the first to report an association of the neurodevelopmental NRG1 rs3735781 GA genotype with the prolonged time to dyskinesia development, which corresponds to the NRG1’s protective role against neuroinflammation and oxidative stress (Xu et al., 2017). The gene discussed is NRG1; the disease is drug-induced dyskinesia.